| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | | Total Revenue | 870,000 | 859,000 | | Cost of Revenue | 163,000 | 157,000 | | | Gross Profit | 707,000 | 702,000 | | | Operating Expenses | | Research Development |
-
|
-
| | Selling General and Administrative | 582,000 | 603,000 | | Non Recurring | 297,000 |
-
| | Others | 66,000 | 57,000 | | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | (238,000) | 42,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
| | Earnings Before Interest And Taxes | (238,000) | 42,000 | | Interest Expense | 63,000 | 83,000 | | Income Before Tax | (301,000) | (41,000) | | Income Tax Expense | (2,000) | 43,000 | | Minority Interest |
-
| (1,000) | | | | Net Income From Continuing Ops | (299,000) | (85,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | (299,000) | (85,000) | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | ($299,000) | ($85,000) |
|
1.29% Nasdaq 
0.1275 (2.15%) 
Income Statement
